Open Journal Systems

LifeTrain: Driving lifelong learning for biomedical professionals

Cath Brooksbank, Christa Janko, Claire Johnson, Wolf See, Hans H. Lindén, Mike Hardman

Abstract

This article describes LifeTrain — the European common framework for continuing professional development in the biomedical sciences. An important goal of LifeTrain is to support biomedical professionals to work collaboratively
across disciplines, sectors and national boundaries. LifeTrain is an open community with a unifying goal; it brings together many excellent, but disparate, activities into a process towards establishing a focused and coherent
framework for continuing professional development in the biomedical sciences. This collaborative approach provides the critical mass to make a major contribution to strengthen the skills and competencies of biomedical professionals in a rapidly changing environment. LifeTrain's signatories, which include multinational pharmaceutical companies, research infrastructures, professional and scientific bodies, higher-education institutes and research institutes, have agreed to the principles of the framework and to continue to collaborate to implement LifeTrain. We warmly invite others to join us.


Keywords

lifelong learning; continuing professional development; LifeTrain; competence; biomedical science

Full Text:

PDF

References

Silva H, Stonier P, Buhler F R, et al. 2013, Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology, vol.4: 105.

http://dx.doi.org/10.3389/fphar.2013.00105

Muindi F and Keller JB, 2015, Emerging network of resources for exploring paths beyond academia. Nature Biotechnology, vol.33: 775–778.

http://dx.doi.org/10.1038/nbt.3282

Christensen C M, 1997, The innovator's dilemma: When new technologies cause great firms to fail. Boston, Massachusetts, USA: Harvard Business School Press.

The Innovative Medicines Initiative (IMI) Scientific Research Agenda: Revision 2011, n.d., viewed September 25, 2015,

What are RIs? European Commission Research and Innovation, n.d., viewed September 18, 2015,

m?pg=what>

European Federation of Pharmaceutical Industries and Associations (EFPIA) home page, n.d., viewed September

, 2015,

Projects: Ongoing projects, Innovative Medicines Initiative (IMI), n.d., viewed September 25, 2015,

Position paper on Horizon 2020: ESFRI Biological and Medical Research Infrastructures, 2013, viewed September 25, 2015,

public/pdf/BMS_RI_PositionHorizon2012.pdf>

Green paper on The European Research Area (ERA): New perspectives [COM(2007) 161], viewed September 17, 2015,

ELEX:52007DC0161>

Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions

[COM(2010) 546], viewed September 25, 2015,

OM:2010:0546:FIN>

Hardman M, Brooksbank C, Johnson C, et al. 2013, LifeTrain: Towards a European framework for continuing professional development in biomedical sciences. Nature Reviews Drug Discovery, vol.12: 407–408.

http://dx.doi.org/10.1038/nrd4026

LifeTrain, n.d., viewed November 11, 2015,

How important is CPD? Professional Associations Research

Network, n.d., viewed September 20, 2015,

Davis NL and Willis CE, 2004, A new metric for continuing medical education credit. Journal of Continuing Education in the Health Professions, vol.24(3): 139–144.

http://dx.doi.org/10.1002/chp.1340240304

Campbell C, Silver I, Sherbino I, et al. 2010, Competency- based continuing professional development. Medical Teacher, vol.32(8): 657–662.

http://dx.doi.org/10.3109/0142159X.2010.500708

Cedefop, 2009, European guidelines for validating nonformal and informal learning. Luxembourg: Office for Official Publications of the European Communities.

Payton A, Janko C, Renn O, et al. 2013, On-course® portal: A tool for in-service training and career development for biomedical scientists. Drug Discovery Today, vol.18(17–18): 803–806.

http://dx.doi.org/10.1016/j.drudis.2013.04.004

Klech H, Brooksbank C, Price S, et al. 2012, European initiative towards quality standards in education and training for discovery, development and use of medicines. European Journal of Pharmaceutical Sciences, vol.45(5): 515–520.

http://dx.doi.org/10.1016/j.ejps.2011.12.005

Nurse P, Sunami A, Polka J, et al. 2015, STEM education: To build a scientist. Nature, vol.523: 371–373.

http://dx.doi.org/10.1038/nj7560-371a

Welch L, Lewitter F, Schwartz R, et al. 2014, Bioinformatics curriculum guidelines: Toward a definition of core competencies. PLoS Computational Biology, vol.10: e1003496.

http://dx.doi.org/10.1371/journal.pcbi.1003496

Ellard S, Thornton J, Aitman T, Boustred C, Brooksbank C, et al. 2015, Developing Clinical Bioinformatics Training in the NHS — a Timeline for Action. UK: Health Education England.

Griesbacher T and Drago F, 2014, European Certified Pharmacologists (EuCP): Standards for postgraduate professional training in pharmacology established by EPHAR, the Federation of European Pharmacological Societies. Intrinsic Activity, vol.2(Suppl. 1): A3.1.

Imi-train: Education and training in the medical, biomedical and pharmaceutical sciences, n.d., viewed September 25, 2015,

EMBL Conference series, n.d., viewed September 25, 2015,

dex.html>

The Innovative Medicines Initiative (IMI), n.d., viewed September 25, 2015,


DOI: http://dx.doi.org/10.18063/JMDS.2015.02.001
(132 Abstract Views, 91 PDF Downloads)

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Cath Brooksbank, Christa Janko, Claire Johnson, Wolf See, Hans H. Lindén, Mike Hardman

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.